CK2 negatively regulates the extinction of remote fear memory

Behav Brain Res. 2024 May 8:465:114960. doi: 10.1016/j.bbr.2024.114960. Epub 2024 Mar 15.

Abstract

Cognitive behavioral therapy, rooted in exposure therapy, is currently the primary approach employed in the treatment of anxiety-related conditions, including post-traumatic stress disorder (PTSD). In laboratory settings, fear extinction in animals is a commonly employed technique to investigate exposure therapy; however, the precise mechanisms underlying fear extinction remain elusive. Casein kinase 2 (CK2), which regulates neuroplasticity via phosphorylation of its substrates, has a significant influence in various neurological disorders, such as Alzheimer's disease and Parkinson's disease, as well as in the process of learning and memory. In this study, we adopted a classical Pavlovian fear conditioning model to investigate the involvement of CK2 in remote fear memory extinction and its underlying mechanisms. The results indicated that the activity of CK2 in the medial prefrontal cortex (mPFC) of mice was significantly upregulated after extinction training of remote cued fear memory. Notably, administration of the CK2 inhibitor CX-4945 prior to extinction training facilitated the extinction of remote fear memory. In addition, CX-4945 significantly upregulated the expression of p-ERK1/2 and p-CREB in the mPFC. Our results suggest that CK2 negatively regulates remote fear memory extinction, at least in part, by inhibiting the ERK-CREB pathway. These findings contribute to our understanding of the underlying mechanisms of remote cued fear extinction, thereby offering a theoretical foundation and identifying potential targets for the intervention and treatment of PTSD.

Keywords: CK2; CX-4945; Fear extinction; MPFC; Remote memory.

MeSH terms

  • Animals
  • Casein Kinase II / metabolism
  • Conditioning, Classical / physiology
  • Extinction, Psychological / physiology
  • Fear* / physiology
  • Mice
  • Prefrontal Cortex / metabolism
  • Stress Disorders, Post-Traumatic* / metabolism

Substances

  • Casein Kinase II
  • Csnk2a2 protein, mouse